Molecular inhibition of phospholipase Cγ signaling abrogates DU-145 prostate tumor cell invasion

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2275-2282

  Turner, Timothy ^a,b   Van Epps Fung, Mark ^a   Kassis, Jareer ^a   Wells, Alan ^a  

^a University of Alabama at Birmingham   (United States)

^b TUSKEGEE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOLIPASE C;

ANIMAL MODEL; ARTICLE; CANCER INVASION; CELL MOTILITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; DIAPHRAGM; HUMANS; ISOENZYMES; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PEPTIDE FRAGMENTS; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031426781     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Partin, A. W., and Coffey, D. S. Benign and Malignant Prostatic Neoplasms: Human Studies, Vol. 49, pp. 293-331. San Diego: Academic Press, 1994.
2. Geldof, A. A., and Rao, B. R. Factors in prostate cancer metastasis. Anticancer Res., 10: 1303-1306, 1990.
3. Linehan, W. M. Inhibition of prostate cancer metastasis: a critical challenge ahead. J. Natl. Cancer Inst., 87: 331-332, 1995.
4. Gittes, R. F. Carcinoma of the prostate. N. Engl. J. Med., 324: 236-245, 1991.
5. Wilt, T. J. Primary care perspectives on early detection and treatment. Fed. Pract., 13: 19-24, 1996.
6. Schultz, M. J. Treating metastatic prostate cancer. Fed. Pract., 13: 14-18, 1996.
7. Dickson, R. B., Johnson, M. D., Maemura, M., and Low, J. Anti-invasive drugs. Breast Cancer Res. Treat., 38: 121-132, 1996.
8. Ruoslahti, E. Integrin signaling and matrix assembly. Tumour Biol., 17: 117-124, 1996.
9. Rinker-Schaeffer, C. W., Chekmareva, M. A., and Mohler, J. L. The role of motility proteins and metastasis-suppressor genes in prostate cancer progression. Stem Cells, 14: 508-516, 1996.
10. Varner, J. A., and Cheresh, D. A. Integrins and cancer. Curr. Opin. Cell Biol., 8: 724-730, 1996.
11. Aaronson, S. A. Growth factors and cancer. Science (Washington DC), 254: 1146-1153, 1991.
12. Libermann, T. A., Razon, N., Bartal, A. D., Yarden, Y., Schlessinger, J., and Soreq, H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res., 44: 753-760, 1984.
13. Yasui, W., Sumiyoshi, H., Hata, J., Kameda, T., Ochiai, A., Ito, H., and Tahara, E. Expression of epidermal growth factor receptor in human gastric and colon carcinomas. Cancer Res., 48: 137-141, 1988.
14. Neal, D. E., Marsh, C, Bennett, M. K., Abel, P. D., Hall, R. R., Sainsbury, J. R. C., and Harris, A. L. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet, 1: 366-368, 1985.
15. Veale, D., Ashcroft, T., Marsh, C., Gibson, G. J., and Harris, A. L. Epidermal growth factor receptors in non-small cell lung cancer. Br. J. Cancer, 55: 513-516, 1987.
16. Klijn, J. G., Berns, P. M., Schmitz, P. I., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev., 13: 3-17, 1992.
17. Radinsky, R., Risin, S., Fan, D., Dong, Z., Bielenberg, D., Bucana, C. D., and Fidler, I. J. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res., 1: 19-31, 1995.
18. Chakrabarty, S., Rajagopal, S., and Huang, S. Expression of anti-sense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells. Clin. Exp. Metastasis, 13: 191-195, 1995.
19. Morris, G. L., and Dodd, J. G. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J. Urol., 143: 1272-1274, 1990.
20. Xie, H., Turner, T., Wang, M-H., Singh, R. K., Siegal, G. P., and Wells, A. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis, 13: 407-419, 1995.
21. Glynne-Jones, E., Goddard, L., and Harper, M. E. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue. Hum. Pathol., 27: 688-694, 1996.
22. Eaton, C. L., Davies, P., and Phillips, M. E. A. Growth factor involvement and oncogene expression in prostatic tumors. J. Steroid Biochem., 30: 341-345, 1988.
23. Myers, R. B., Kudlow, J. E., and Grizzle, W. E. Expression of transforming growth factor alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Mod. Pathol., 6: 733-737, 1993.
24. Turner, T., Chen, P., Goodly, L. J., and Wells, A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin. Exp. Metastasis, 14: 409-418, 1996.
25. Chen, P., Xie, H., Sekar, M. C., Gupta, K. B., and Wells, A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but MAP kinase activity is not sufficient for induced cell movement. J. Cell Biol., 127: 847-857, 1994.
26. Kundra, V., Escobedo, J. A., Kazlauskas, A., Kim, H. K., Rhee, S. G., Williams, L. T., and Zetter, B. R. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature (Lond.), 367: 474-476, 1994.
27. Bornfeldt, K. E., Raines, E. W., Nakano, T., Graves, L. M., Krebs, E. G., and Ross, R. Insulin-like growth factor-1 and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signalling pathways that are distinct from those of proliferation. J. Clin. Invest., 93: 1266-1274, 1994.
28. Homma, Y., and Takenawa, T. Inhibitory effect of src homology (SH) 2/SH3 fragments of phospholipase C-γ on the catalytic activity of phospholipase C isoforms: identification of a novel phospholipase C inhibitor region. J. Biol. Chem., 267: 21844-21849, 1992.
29. Chen, P., Xie, H., and Wells, A. Mitogenic signaling from the EGF receptor is attenuated by a motility-associated phospholipase C-γ/protein kinase C feedback mechanism. Mol. Biol. Cell, 7: 871-881, 1996.
30. Chen, P., Murphy-Ullrich, J., and Wells, A. A role for gelsolin in actuating EGF receptor-mediated cell motility. J. Cell Biol., 134: 689-698, 1996.
31. Knox, J. D., Mack, C. F., Powell, W. C., Bowden, G, T., and Nagle, R. B. Prostate tumor cell invasion: a comparison of orthotopic and ectopic models. Invasion Metastasis, 13: 325-331, 1993.
32. Powell, W. C., Knox, J. D., Navre, M., Grogan, T. M., Kittelson, J., Nagle, R. B., and Bowden, G. T. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res., 53: 417-422, 1993.
33. Turner, T., Jackson, W. H., Pettit, G. R., Wells, A., and Kraft, A. S. Treatment of human prostate cancer with dolastatin 10, a peptide isolated from a marine shell-less mollusc, The Prostate, in press, 1998.
34. Sekar, M. C., Dixon, J. F., and Hokin, L. E. The formation of inositol 1,2-cyclin 4,5-trisphosphate and inositol 1,2-cyclic 4 bisphosphate on stimulation of mouse pancreatic minilobules with carbamylcholine. J. Biol. Chem., 262: 340-344, 1987.
35. Peterson, G., and Barnes, S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate, 22: 335-345, 1993.
36. Wells, A., Welsh, J, B., Lazar, C. S., Wiley, H. S., Gill, G. N., and Rosenfeld, M. G. Ligand-induced transformation by a non-internalizing EGF receptor. Science (Washington DC), 247: 962-964, 1990.
37. Chen, P., Gupta, K., and Wells, A. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J. Cell Biol., 124: 547-555, 1994.
38. David, M., Wong, L., Flavell, R., Thompson, S. A., Wells, A., Larner, A. C., and Johnson, G. R. STAT activation by epidermal growth factor (EGF) and amphiregulin: requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem., 271; 9185-9188, 1996.